Alemtuzumab (Anti-CD52)Alemtuzumab (Anti-CD52)
Move your mouse over image or click to enlarge

Alemtuzumab (Anti-CD52)

Alemtuzumab (Anti-CD52) is a humanized monoclonal antibody targeting against CD52. Alemtuzumab selectively targets the CD52 antigen to induce profound lymphocyte depletion, followed by recovery of T and B cells with regulatory phenotypes. MW:145.5 KD.
Cat# Size Price Qty Buy
A2553-1mg*25 1mg*25
£5,626.00
A2553-1mg*5 1mg*5
£1,875.00
A2553-1mg 1mg
£630.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2553

Related Documents